The three biggest Medicare Advantage insurers — UnitedHealth, Humana, and CVS/Aetna — are all shedding plans for 2027.

Crop concentrated professional senior male physician in white robe with stethoscope standing in modern hospital hallway and reading medical case records in daylight

The three largest names in Medicare Advantage are entering the 2027 plan year by subtracting rather than adding. UnitedHealth, Humana, and CVS Health’s Aetna unit have each signaled that they will drop coverage options and abandon unprofitable counties, a retreat that lands just a year after roughly 2.6 million enrollees already watched a plan disappear. For older Americans who built a monthly budget around a zero-premium plan and a familiar roster of in-network doctors, a shrinking menu is a direct financial event, not an abstract corporate maneuver.

Why the Big Three Are Retreating From Unprofitable Counties

The pullback traces back to arithmetic. The Centers for Medicare & Medicaid Services set an average Medicare Advantage payment increase of about 2.48 percent for the coming year, a figure that has not kept pace with how fast medical claims are climbing as older patients use more care. When reimbursement lags cost, insurers respond in two ways: they exit the geographies where a plan loses money, and they trim the extra benefits — grocery cards, over-the-counter allowances, dental riders — that once made these plans a bargain.

The scale of the 2027 retreat is coming into focus. Humana has told investors it will pursue targeted plan exits expected to affect roughly 600,000 members, while UnitedHealth has weighed pulling out of 34 counties across a dozen states, a move that could displace more than 20,000 additional enrollees, according to reporting on the escalating exits. Aetna, the third of the trio, has said it is prioritizing profit margins over membership growth for the contract year — the same logic pushing its rivals out of their least profitable markets. Together the three companies dominate Medicare Advantage enrollment, so decisions made in their boardrooms ripple through millions of mailboxes.


Free retirement updates: Enrollment and claim windows come and go, and missing one can cost real money. The free Retirement Shield newsletter keeps readers ahead of the deadlines that matter. Sign up free.

What a Non-Renewal Notice Means Before December 7

Members whose plans are being discontinued receive a formal non-renewal notice in the fall, arriving alongside the Annual Notice of Change that spells out how a surviving plan’s costs and coverage will shift. The window to respond is fixed rather than flexible: Medicare’s open enrollment period runs from October 15 through December 7, with any change taking effect the following January 1. That gap between the notice and the deadline is where costly mistakes happen, because a discontinued plan does not roll into a comparable one automatically.

An enrollee who takes no action after a plan is terminated is generally returned to Original Medicare — but without the prescription drug coverage that a separate Part D plan provides, and exposed to a lifelong Part D late-enrollment penalty for the months spent uncovered. Reviewing the replacement options during the window, rather than after it, is the difference between a chosen plan and a default one.

There is also a second, narrower window that many members overlook. The Medicare Advantage Open Enrollment Period, which runs from January 1 to March 31, lets someone already in an Advantage plan switch to a different one or drop back to Original Medicare once during that stretch — a limited do-over for anyone who lands in the wrong replacement after the December deadline. It does not, however, allow a first move from Original Medicare into Advantage, and it does not reopen the guaranteed Medigap rights that a plan termination briefly grants.

The Money Math of Choosing 2027 Coverage

The replacement decision comes down to cost structure. One path is another Medicare Advantage plan, which may again carry a low premium but ties care to a network that can shift during the year. The other is Original Medicare paired with a stand-alone Part D drug plan and, for those who want predictable bills, a Medigap supplement that covers much of what Original Medicare leaves behind. Each route carries a different mix of monthly premiums and out-of-pocket exposure, and the cheapest premium is not always the cheapest year.

The penalties for drifting are concrete. A retiree who goes without creditable drug coverage after a plan ends accrues a Part D late-enrollment penalty of roughly 1 percent of the national base premium for every month left uncovered, an amount permanently tacked onto the premium once coverage resumes. The Medigap protection is just as time-bound: the guaranteed-issue right to buy a supplement without health screening lasts only 63 days past the date the terminated plan’s coverage ends. For a member weighing whether to act on a non-renewal notice, those two clocks turn a paperwork chore into a decision with a lasting price tag.

One escape hatch is reserved for a narrower group. A beneficiary who tried Medicare Advantage for the first time gets a 12-month trial right to return to Original Medicare and buy any Medigap policy on a guaranteed basis, a one-time safety valve that does not renew on later switches. For the millions who have cycled through Advantage before, no such second trial exists, which leaves the termination-triggered 63-day window as their only underwriting-free path back to a supplement.

Timing shapes that math in a way many members miss. Federal rules on joining or switching a plan give a beneficiary whose Medicare Advantage plan is terminated a limited, one-time right to buy certain Medigap policies without answering health questions — a protection that can vanish once the clock runs out. For a retiree weighing a familiar plan’s disappearance against the premiums of its replacements, the exits announced for 2027 are less a distant headline than a line item that will land on next year’s bank statement, decided during a window that closes on December 7.

This article was produced with the assistance of artificial intelligence and reviewed by The Financial Wire editorial team.

More Financial Reading

Leave a Reply

Your email address will not be published. Required fields are marked *